{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:00:02Z","timestamp":1792699202121,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007281","name":"National Drug and Alcohol Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022178","name":"National Coronial Information System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022178","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.drugalcdep.2026.113085","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:23:45Z","timestamp":1771374225000},"page":"113085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Changing characteristics in the 2020s of fatal \u2018novel\u2019 benzodiazepine toxicity cases in Australia"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-7055","authenticated-orcid":false,"given":"Shane","family":"Darke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5863-635X","authenticated-orcid":false,"given":"Johan","family":"Duflou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lappin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-2026","authenticated-orcid":false,"given":"Amy","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2026.113085_bib1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0025802420950273","article-title":"Flubromazolam detection in five post-mortem cases","volume":"60","author":"Abdul","year":"2020","journal-title":"Med. Sci. Law"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib2","series-title":"Disposition of Toxic Drugs and Chemicals in Man (12th Edition)","author":"Baselt","year":"2020"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib3","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.5858\/arpa.2021-0287-OA","article-title":"Updating normal organ weights using a large current sample database","volume":"146","author":"Bell","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/dta.3119","article-title":"What's in fake \u2018Xanax\u2019? A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets","volume":"14","author":"Blakey","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ph14060560","article-title":"Designer Benzodiazepines: A review of toxicology and public health risks","volume":"4","author":"Brunetti","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111777","article-title":"Fentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs. A review of over 1250 benzo-dope\/fentanyl toxicity cases in Alberta, Canada","volume":"350","author":"Chatterton","year":"2023","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib7","article-title":"Characteristics of fatal \u2018novel\u2019 synthetic benzodiazepine toxicity in Australia","volume":"331","author":"Darke","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/add.16377","article-title":"A descriptive coronial study of heroin toxicity deaths in Australia, 2020-2022: characteristics, toxicology, and survival times","volume":"119","author":"Darke","year":"2024","journal-title":"Addict"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/dar.13940","article-title":"Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001-2023","volume":"44","author":"Darke","year":"2025","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/jat\/bkae075","article-title":"Deaths involving novel benzodiazepines in Victoria, Australia from 2018 to 2022","volume":"48","author":"Drummer","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/neurolint14030053","article-title":"Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol. Int."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jat\/bkae079","article-title":"The rise of bromazolam in postmortem cases from Travis County, TX, and surrounding areas: 2021\u20132023","volume":"49","author":"Ellefsen","year":"2025","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109244","article-title":"Significant toxicity following an increase in poisonings with designer benzodiazepines in the Netherlands between 2010 and 2020","volume":"231","author":"Essink","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib14","article-title":"The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction\u2014A Narrative Review","volume":"45","author":"Freestone","year":"2026","journal-title":"Drug. Rev."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jat\/bkaa043","article-title":"Blood concentrations of designer benzodiazepines relation to impairment and findings in forensic cases","volume":"44","author":"Heide","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0025802420973814","article-title":"Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases","volume":"61","author":"Hikin","year":"2021","journal-title":"Med. Sci. Law"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111891","article-title":"Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales","volume":"354","author":"Hikin","year":"2024","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib18","series-title":"SPSS for Windows, 29.0","author":"IBM inc","year":"2024"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.110101","article-title":"Femoral blood concentrations of flualprazolam in 33 postmortem cases","volume":"307","author":"Kriikku","year":"2020","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104236","article-title":"Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK","volume":"144","author":"McAuley","year":"2025","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jat\/bkad005","article-title":"Bromazolam blood concentrations in postmortem cases\u2014a British Columbia perspective","volume":"47","author":"M\u00e9rette","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/10408444.2021.1907303","article-title":"Designer benzodiazepines versus prescription benzodiazepines can structural relation predict the next step?","volume":"51","author":"Moustafa","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib23","series-title":"Operational Statistics, July 2025","author":"National Coronial Information System","year":"2025"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jat\/bkaa098","article-title":"Quantification of flualprazolam in blood by LC\u2013MS-MS: a case series of nine deaths","volume":"45","author":"Rice","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/add.16520","article-title":"The surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco","volume":"119","author":"Rodda","year":"2024","journal-title":"Addict"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib26","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/dar.14054","article-title":"Changes over time in novel benzodiazepines contributing to fatal overdoses in Victoria, Australia","volume":"44","author":"Schumann","year":"2025","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2026.113085_bib27","series-title":"Australian Drug Trends 2025: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews","author":"Sutherland","year":"2025"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib28","series-title":"Australian Drug Trends 2025: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews","author":"Sutherland","year":"2025"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104245","article-title":"Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia-Victoria project 2020-2022","volume":"122","author":"Syrjanen","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2026.113085_bib30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/15563650.2023.2229951","article-title":"Emerging Drugs Network of Australia Investigators, 2023. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA)","volume":"61","author":"Weber","year":"2023","journal-title":"Clin. Toxicol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871626000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871626000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:07:39Z","timestamp":1776182859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871626000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"alternative-id":["S0376871626000669"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2026.113085","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing characteristics in the 2020s of fatal \u2018novel\u2019 benzodiazepine toxicity cases in Australia","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2026.113085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113085"}}